Market Overview:
The global Dupuytren contracture drug market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing incidence of Dupuytren contracture, rising awareness about the disease, and technological advancements in the field of treatment options for Dupuytren contracture. Based on type, the global Dupuytren contracture drug market is segmented into bupivacaine ER, MWPC-003, and others. Bupivacaine ER dominates the market owing to its high efficacy and safety profile. Based on application, the global Dupuytren contracture drug market is segmented into clinic, hospital, and others. Clinic dominates the market due to early diagnosis and treatment options available at clinics.
Product Definition:
Dupuytren Contracture Drug is a drug that is used to treat Dupuytren Contracture. Dupuytren Contracture is a condition where the fingers curl into the palm of the hand. The importance of Dupuytren Contracture Drug is that it can help to straighten the fingers and improve function in people with this condition.
Bupivacaine ER:
Bupivacaine ER is a semi-synthetic opioid with a weak agonist effect on the mu-opioid receptor. Bupivacaine ER has been reported to have around 1/10th the potency of Morphine, which makes it one of the weakest opioids known. However, in animal models, it has been found to possess an analgesic effect at doses as low as 0.05mg/kg (5 micrograms).
MWPC-003:
MWPC-003 is a novel compound which has been developed by Wuhan Jinyintan Pharmaceutical Co., Ltd. It is a type of protein kinase C (PKC) inhibitor and it's main function is to inhibit the Rho-associated coiled coil 1 (RAC1) and Rac1 related coiled coil 2 (RRC2).
Application Insights:
The clinic application segment held the largest share of more than 60.0% in 2017. The growing use of contracture drugs for pain management and Dupuytren's disease treatment in clinics is expected to be a key factor driving the market growth over the forecast period. In addition, increasing awareness about contracture disease among general practitioners is further anticipated to propel demand for these products from clinics over the coming years.
Hospital application accounted for a significant share owing to rising prevalence and awareness about early diagnosis and effective treatment procedures of contracture disease, especially in developing countries like India, China and Brazil where healthcare infrastructure is still evolving at a rapid pace. Furthermore, stringent government regulations related with safety & hygiene are also expected to drive hospital applications across developing countries such as China, India & Brazil which would eventually benefit market growth on a global scale during future phases of expansion.
Other applications include personal care products (soaps), cosmetic surgery (foreskin reduction).
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017. The region is expected to maintain its lead throughout the forecast period owing to increasing cases of hand, foot and mouth disease (HFMD) and prevalence of Dupuytren's contracture among American population. In addition, high adoption rate for advanced therapeutics with faster results is driving regional growth.
Asia Pacific market was valued at USD X million in 2017 and is anticipated to witness lucrative CAGR during the forecast period due to rising healthcare expenditure by governments as well as private sectors coupled with growing awareness about early diagnosis & treatment options for DCs related diseases such as Dupuytren's contracture, osteoporosis etc.
Growth Factors:
- Increasing incidence of Dupuytren Contracture Drug due to changing lifestyle and increasing awareness about the disease.
- Growing demand for minimally invasive surgeries for the treatment of Dupuytren Contracture Drug.
- Technological advancements in the field of surgery that would help in early diagnosis and treatment of Dupuytren Contracture Drug.
- Rising number of research studies on Dupuytren Contracture Drug that would help in understanding the disease better and finding new treatments for it.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dupuytren Contracture Drug Market Research Report
By Type
Bupivacaine ER, MWPC-003, Others
By Application
Clinic, Hospital, Others
By Companies
MediWound Ltd, Pacira Pharmaceuticals Inc, MediWound Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global Dupuytren Contracture Drug Market Report Segments:
The global Dupuytren Contracture Drug market is segmented on the basis of:
Types
Bupivacaine ER, MWPC-003, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinic, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- MediWound Ltd
- Pacira Pharmaceuticals Inc
- MediWound Ltd
Highlights of The Dupuytren Contracture Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bupivacaine ER
- MWPC-003
- Others
- By Application:
- Clinic
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dupuytren Contracture Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dupuytren contracture drug is a medication used to treat Dupuytren contracture. It is a type of corticosteroid.
Some of the major players in the dupuytren contracture drug market are MediWound Ltd, Pacira Pharmaceuticals Inc, MediWound Ltd.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dupuytren Contracture Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dupuytren Contracture Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dupuytren Contracture Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dupuytren Contracture Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dupuytren Contracture Drug Market Size & Forecast, 2020-2028
4.5.1 Dupuytren Contracture Drug Market Size and Y-o-Y Growth
4.5.2 Dupuytren Contracture Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Bupivacaine ER
5.2.2 MWPC-003
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Clinic
6.2.2 Hospital
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dupuytren Contracture Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dupuytren Contracture Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Bupivacaine ER
9.6.2 MWPC-003
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Clinic
9.10.2 Hospital
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Bupivacaine ER
10.6.2 MWPC-003
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Clinic
10.10.2 Hospital
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Bupivacaine ER
11.6.2 MWPC-003
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Clinic
11.10.2 Hospital
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Bupivacaine ER
12.6.2 MWPC-003
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Clinic
12.10.2 Hospital
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Bupivacaine ER
13.6.2 MWPC-003
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Clinic
13.10.2 Hospital
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dupuytren Contracture Drug Market: Competitive Dashboard
14.2 Global Dupuytren Contracture Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 MediWound Ltd
14.3.2 Pacira Pharmaceuticals Inc
14.3.3 MediWound Ltd
